Company Analysis

OptimizeRx Corporation (OPRX)

Nasdaq: OPRX · Services-Business Services, NEC · Waltham, MA · filing with the SEC since 2008
Grade5.0
◀ Past 5.6● Present 4.9▶ Future 4.8

Who runs OptimizeRx Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Silvestro Stephen L
Chief Executive Officer. First filing May 2019, latest Aug 24, 2026, 10 filings in all.
Officers reporting now
8
of 13 people with a filing in the last fifteen months
Directors reporting now
5
25 people on the record since 2009
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
D'Silva Andrew J.Chief Business OfficerAug 2025Oct 2, 2026none
Silvestro Stephen LChief Executive OfficerMay 2019Aug 24, 20261 · $0.00
Merrell Brendan W.CHIEF OPERATING OFFICERAug 2025Aug 24, 2026none
Odence-Ford MarionChief Legal & Admin OfficerFeb 2021Aug 24, 2026none
Stelmakh EdwardChief Finance & Strat OfficerOct 2021Aug 24, 20261 · $0.00
Spangler Patrick DSVP of Product & StrategyMar 2018Jun 10, 2026none
Greco TheresaChief Commercial OfficerOct 2023May 18, 2026none
Besch DougChief Product & Tech OfficerOct 2022Dec 23, 2025none
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Klema CathydirectorFeb 2024Jun 10, 2026none
Lang James PauldirectorMar 2017Jun 10, 2026none
Presti Mariyamma VarghesedirectorApr 2026Jun 10, 2026none
Vos Ellen O'ConnordirectorOct 2015Jun 10, 2026none
Wasson Gregory DdirectorAug 2020Jun 10, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton OPRX · research, not advice